396 related articles for article (PubMed ID: 7562760)
1. Anti-CENP-B response in sera of uranium miners exposed to quartz dust and patients with possible development of systemic sclerosis (scleroderma).
Conrad K; Stahnke G; Liedvogel B; Mehlhorn J; Barth J; Blasum C; Altmeyer P; Sönnichsen N; Frank KH
J Rheumatol; 1995 Jul; 22(7):1286-94. PubMed ID: 7562760
[TBL] [Abstract][Full Text] [Related]
2. Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA.
Mahler M; You D; Baron M; Taillefer SS; Hudson M; ; Fritzler MJ
Clin Chim Acta; 2011 Oct; 412(21-22):1937-43. PubMed ID: 21756890
[TBL] [Abstract][Full Text] [Related]
3. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.
Vázquez-Abad D; Grodzicky T; Senécal JL
Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829
[TBL] [Abstract][Full Text] [Related]
4. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
Russo K; Hoch S; Dima C; Varga J; Teodorescu M
J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of anti-centromere antibody and anti-CENP-B antibody in sera of patients with primary biliary cirrhosis].
Onozuka Y; Shibata M; Yonezawa H; Terauti K; Miyachi K; Ueno Y
Rinsho Byori; 1996 Sep; 44(9):877-82. PubMed ID: 8911074
[TBL] [Abstract][Full Text] [Related]
6. Clinical correlates of CENP-A and CENP-B antibodies in a large cohort of patients with systemic sclerosis.
Hudson M; Mahler M; Pope J; You D; Tatibouet S; Steele R; Baron M; ; Fritzler M
J Rheumatol; 2012 Apr; 39(4):787-94. PubMed ID: 22467948
[TBL] [Abstract][Full Text] [Related]
7. The pathogenic 16/6 idiotype in patients with silica associated systemic lupus erythematosus (SLE) and uranium miners with increased risk for development of SLE.
Conrad K; Levy Y; Blank M; Mehlhorn J; Frank KH; Roch B; Shoenfeld Y
J Rheumatol; 1998 Apr; 25(4):660-6. PubMed ID: 9558166
[TBL] [Abstract][Full Text] [Related]
8. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
9. CENP-O, a protein localized at the centromere throughout the cell cycle, is a novel target antigen in systemic sclerosis.
Saito A; Muro Y; Sugiura K; Ikeno M; Yoda K; Tomita Y
J Rheumatol; 2009 Apr; 36(4):781-6. PubMed ID: 19286853
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus.
Nakano M; Ohuchi Y; Hasegawa H; Kuroda T; Ito S; Gejyo F
J Rheumatol; 2000 Jun; 27(6):1403-7. PubMed ID: 10852261
[TBL] [Abstract][Full Text] [Related]
11. Recognition of Granzyme B-generated autoantigen fragments in scleroderma patients with ischemic digital loss.
Schachna L; Wigley FM; Morris S; Gelber AC; Rosen A; Casciola-Rosen L
Arthritis Rheum; 2002 Jul; 46(7):1873-84. PubMed ID: 12124872
[TBL] [Abstract][Full Text] [Related]
12. Clinical and serological evaluation of a novel CENP-A peptide based ELISA.
Mahler M; Maes L; Blockmans D; Westhovens R; Bossuyt X; Riemekasten G; Schneider S; Hiepe F; Swart A; Gürtler I; Egerer K; Fooke M; Fritzler MJ
Arthritis Res Ther; 2010; 12(3):R99. PubMed ID: 20487535
[TBL] [Abstract][Full Text] [Related]
13. The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome.
Zimmermann C; Steiner G; Skriner K; Hassfeld W; Petera P; Smolen JS
Arthritis Rheum; 1998 Nov; 41(11):1938-45. PubMed ID: 9811047
[TBL] [Abstract][Full Text] [Related]
14. High frequency of neoplasia in patients with autoantibodies to centromere protein CENP-F.
Rattner JB; Rees J; Whitehead CM; Casiano CA; Tan EM; Humbel RL; Conrad K; Fritzler MJ
Clin Invest Med; 1997 Oct; 20(5):308-19. PubMed ID: 9336656
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of antibodies to recombinant CENP-B in primary biliary cirrhosis: nuclear immunofluorescence patterns and ELISA reactivities.
Parveen S; Morshed SA; Nishioka M
J Gastroenterol Hepatol; 1995; 10(4):438-45. PubMed ID: 8527711
[TBL] [Abstract][Full Text] [Related]
16. Proteomics characterization of CENP-B epitope in Moroccan scleroderma patients with anti-centromere autoantibodies.
Zian Z; Bennani Mechita M; Hamdouch K; Maamar M; Barakat A; Ghailani Nourouti N; El Aouad R; Valdivia MM; Arji N
Immunol Lett; 2020 May; 221():1-5. PubMed ID: 32057908
[TBL] [Abstract][Full Text] [Related]
17. Proteins responsible for anticentromere activity found in the sera of patients with CREST-associated Raynaud's phenomenon.
Kremer L; Alvaro-Gracia JM; Ossorio C; Avila J
Clin Exp Immunol; 1988 Jun; 72(3):465-9. PubMed ID: 3048807
[TBL] [Abstract][Full Text] [Related]
18. Anticentromere-A and anticentromere-B antibodies show high concordance and similar clinical associations in patients with systemic sclerosis.
Hanke K; Becker MO; Brueckner CS; Meyer W; Janssen A; Schlumberger W; Hiepe F; Burmester GR; Riemekasten G
J Rheumatol; 2010 Dec; 37(12):2548-52. PubMed ID: 20889593
[TBL] [Abstract][Full Text] [Related]
19. CENP-B autoantigen is a conserved protein from humans to higher plants: identification of the aminoterminal domain in Phaseolus vulgaris.
Barbosa-Cisneros O; Fraire-Velázquez S; Moreno J; Herrera-Esparza R
Rev Rhum Engl Ed; 1997 Jun; 64(6):368-74. PubMed ID: 9513608
[TBL] [Abstract][Full Text] [Related]
20. Localization of the centromere protein CENP-B using scleroderma sera and evidence for a role in centromere survival.
Barbosa-Cisneros O; Avalos-Diaz E; Vera O; Moreno J; Herrera-Esparza R
Rev Rhum Engl Ed; 1998 Jan; 65(1):15-20. PubMed ID: 9523381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
